TC Biopharm Holdings PLC
13F holders, Q3 2024 (September 30)1holders −7
0new positions
8sold out
$5.29avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding TC Biopharm Holdings PLC in their 13F filings, down 7 from Q2 2024. 0 opened new positions and 8 sold out. The largest holder was Rhumbline Advisers ($439).
- Company
- TC Biopharm Holdings PLC
- CUSIP
- 87807D400
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 8 | $76K |
All 13F filers, Q2 2024 → Q3 2024: 93,400 shares sold, net −93,400 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Reduce -90.2% | 83 | $439 |
"% of holder's portfolio" is TC BIOPHARM HOLDINGS PLC's weight in each manager's 13F, not the share of TC Biopharm Holdings PLC the manager owns.